Examples of 'anti-proliferative' in a sentence
Meaning of "anti-proliferative"
anti-proliferative (adjective) - describes substances or treatments that inhibit or slow down the growth and spread of cells or organisms
How to use "anti-proliferative" in a sentence
Basic
Advanced
anti-proliferative
These products have an anti-proliferative activity.
The anti-proliferative agent is everolimus.
It exhibits antiviral and anti-proliferative activity.
An anti-proliferative agent is also included, in a form suitable for administration.
Preferably such agents have an anti-proliferative effect.
Progesterone has an anti-proliferative effect on mucosa and accelerates desquamation.
Derivatives of squaric acid with anti-proliferative activity.
Rapamycin is an anti-proliferative agent that can be effective at a concentration of about 1 nM.
The methods comprise administration of an anti-proliferative agent.
The anti-proliferative activities of selective sets of compounds are listed below.
Use of radiolabelled materials as anti-proliferative agents is also possible.
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders.
The compounds are also tested for anti-proliferative activity.
Anti-proliferative agents can include drugs such as amlodipine and doxazosin.
The regimen further comprises administration of an anti-proliferative agent.
See also
In certain embodiments said anti-proliferative agent is not a pituitary down-regulator.
They can be administered alone or in combination with anti-proliferative drugs.
In particular embodiments said anti-proliferative agent is not a hormone-based drug.
Anti-proliferative drugs such a paclitaxel and its derivatives and analogs.
Radiation therapy may also be considered an anti-proliferative cytotoxic agent.
The anti-proliferative agent may also be given every other week.
The resulting concentrates have extremely strong anti-proliferative effects.
The preferred anti-proliferative antioxidant is manganese, especially useful for psoriasis.
Others materials work only in combination with anti-proliferative drugs.
A preferred anti-proliferative agent for use in the present invention is dexamethasone.
Moreover, they can be administered alone or in combination with anti-proliferative drugs.
This anti-proliferative activity of borrelidin was shown to be general towards various cell lines.
In particular, certain derivatives of squaric acid are known to possess anti-proliferative activity.
In one aspect, the active agent is an anti-proliferative agent such as an antineoplastic agent.
In an embodiment, a therapeutic compound disclosed herein is a chemotherapeutic agent or an anti-proliferative agent.
This reflects the anti-proliferative effect of progestogen and androgen on endometrial tissue.
The compounds of the present invention showed potent anti-proliferative activity.
In lymphoma or leukemia patients, anti-proliferative binding agents are preferably directed to cancer cells.
Therefore increased affinity of antibodies to FcYRs may result in enhanced anti-proliferative effects.
Resistance has also been encountered with anti-proliferative agents used in cancer chemotherapy.
Further research on flavones as a class of compounds offers a potential approach to anti-proliferative therapy.
Proliferative and anti-proliferative effects are seen as changes in colony formation as compared to controls.
If data are available, stents coated with different anti-proliferative agents will be compared.
These anti-proliferative effects are thought to apply to other cancers and medical conditions as well.
Cannabinoids have been shown to have an anti-proliferative effect on different cancer cell lines.
In another embodiment, a composition includes a peptide or peptidomimetic sequence and an anti-proliferative agent.
Scytonemin showed pronounced anti-proliferative effects on various human cell lines in vitro.
Mycophenolate is potent and can be used in place of the older anti-proliferative azathioprine.
This anti-proliferative activity is superior to some of the existing approved drugs of this class.
The implant 's utility is enhanced by incorporation of an anti-proliferative drug with sustained release.
Standard anti-proliferative chemotherapeutic agents have not been successful as treatment for prostate cancer.
It is herein disclosed the manufacture of drugs having an anti-proliferative effect on carcinoma cells.
The anti-proliferative drug can be a natural proteineous substance such as a cytotoxin or a synthetic molecule.
As such, it is also thought to have anti-proliferative effects against cancer growth and metastasis.
Anti-proliferative agents can also be useful in treating autoimmune diseases and inflammatory disease.
